Ann: Proposed issue of Securities - BNO, page-5

it was set to drop 16.5٪ because that's what it's being diluted by.

The big test is going to be the 105 phase 2 results that they're getting next month(?). Im not confident that they're going to be positive.

you'd have to think that a negative result would halve the share price?

That puts us below the capital raise price.

Also it looks like demad has dropped right off. Because Angermeyer has covered the raise @ $0.06 there's going to be a bunch of shenanigans over the next few weeks.

More pain for shareholders.

glta